Anavex Life Sciences Corp (AVXL)

[kevindenver]

I often tease fellow investor's to beware of establishing a cult mentality for a compound or CEO. But, if S1R modulation and maybe muscarinic receptor ideas pan out as we hope, it was this scrappy management crew that pulled it off.

Think of it, from OTCQX REVERSE MERGER with LPC style financing on start up to NASDAQ to Nasdaq Global Select Market.

So yea, Time of the Year is would be just fine.

I do wonder what if the company and the at the time novel S1R ideas, went a more traditional financing route? Regardless it's been an interesting journey.